What are the trends in the treatment of multiple sclerosis in recent studies? – A bibliometric analysis with global productivity during 1980–2021

医学 多发性硬化 格拉默 芬戈莫德 主题(文档) 生产力 文献计量学 家庭医学 图书馆学 精神科 计算机科学 宏观经济学 经济
作者
Serdar Aykaç,Sinan Eliaçık
出处
期刊:Multiple sclerosis and related disorders [Elsevier BV]
卷期号:68: 104185-104185 被引量:14
标识
DOI:10.1016/j.msard.2022.104185
摘要

There is no bibliometric analysis in the literature on the subject of the treatment of multiple sclerosis (MS), which is a disease with increasing prevalence, severely affecting the life and quality of life of patients. The purpose of this study was to analyze the scientific articles published on the subject of MS treatment, using bibliometric approaches and statistical methods, and thereby show the trend subjects and global productivity.From 14,443 publications on the subject of MS between 1980 and 2021, 5010 in the category of article were retrieved from the Web of Science and analyzed statistically. Bibliometric network visualization diagrams were created to determine trend subjects, collaborations between countries and citation analyzes. Exponential Smoothing estimation was used to predict the number of articles to be published in the next 5 years. Correlations were determined using Spearman's correlation analysis.The 3 countries contributing the most to literature were found to be the USA (1385, 37.6%), Italy (700, 13.9%), and Germany (694, 13.8%). The most productive author was Hartung Hans-Peter (n = 82) and the most productive institution was the University of London (n = 198). The three most productive journals were the Multiple Sclerosis Journal (n = 354), Multiple Sclerosis and Related Disorders (n = 224), and Neurology (n = 204). The most studied subjects can be listed from past to present as interferon beta, disease-modifying treatment or drugs, relapsing, natalizumab, fingolimod, glatiramer acetate, fatigue, alemtuzumab, cytokines, mitoxantrone, MRI, adherence, depression, experimental autoimmune encephalomyelitis, quality of life, and biomarkers.The scientific production related to MS treatment shows growth chronologically over the years. According to the findings of the analysis done to identify trending subjects, the key words studied in recent years were determined to be fingolimod, alemtuzumab, disease-modifying therapy, ocrelizumab, teriflunomide, rituximab, dimethyl fumarate, safety, biomarkers, COVID-19, oxidative stress, inflammation, vitamin D, relapsing multiple sclerosis, cost-effectiveness, cladribine tablets, and medication adherence. Western countries, especially European countries, the USA, and Canada lead the way in research and scientific collaboration on the subject of MS treatment. These findings can contribute to a better understanding of this subject and can help provide new ideas for further studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
蓝色雪狐完成签到,获得积分10
2秒前
哈哈发布了新的文献求助10
2秒前
2秒前
4秒前
搜集达人应助段段采纳,获得10
5秒前
DingShicong完成签到 ,获得积分10
5秒前
Miracle完成签到,获得积分10
6秒前
研友_VZG7GZ应助小刘采纳,获得10
6秒前
feifei发布了新的文献求助30
6秒前
丘比特应助悠悠爱学习采纳,获得10
7秒前
Janet发布了新的文献求助10
7秒前
研友_Z33zkZ发布了新的文献求助10
7秒前
CR7应助小宋宋采纳,获得20
7秒前
852应助望北楼主采纳,获得10
7秒前
七月流火给阅知的求助进行了留言
7秒前
kiss完成签到,获得积分10
8秒前
白色风车发布了新的文献求助10
8秒前
8秒前
毛毛虫发布了新的文献求助10
9秒前
菲菲完成签到,获得积分10
9秒前
LYSM应助宁阿霜采纳,获得10
10秒前
愤怒的茉莉完成签到,获得积分10
10秒前
纯真醉波完成签到 ,获得积分10
10秒前
10秒前
leez完成签到,获得积分20
11秒前
踏实的星星完成签到,获得积分20
11秒前
CipherSage应助CJ采纳,获得10
11秒前
11秒前
欣慰的笑阳完成签到 ,获得积分10
11秒前
小二郎应助Spark采纳,获得10
11秒前
12秒前
12秒前
zz发布了新的文献求助10
13秒前
科目三应助饱满的小甜瓜采纳,获得10
13秒前
Akim应助科研通管家采纳,获得10
13秒前
SYLH应助科研通管家采纳,获得10
13秒前
科研通AI2S应助科研通管家采纳,获得10
13秒前
SYLH应助科研通管家采纳,获得10
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974844
求助须知:如何正确求助?哪些是违规求助? 3519270
关于积分的说明 11197844
捐赠科研通 3255496
什么是DOI,文献DOI怎么找? 1797791
邀请新用户注册赠送积分活动 877187
科研通“疑难数据库(出版商)”最低求助积分说明 806202